Class Biology with Agile AI and Chemistry Automation for Rapid Discovery of Better Molecules for Highly Valuable G Protein-Coupled Receptor (GPCR) TargetsMENLO PARK, Calif., May 21, 2025 (GLOBE ...

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

The global ablation technology market was valued at US$ 6.82 billion in 2024 and is projected to reach US$ 16.74 billion by 2034, growing at a CAGR of 9.82% during the forecast period 2025?2034.

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

This service development policy sets out NHS England’s approach for making decisions about which new treatments and interventions to routinely commission, and the approach used for updating existing ...